https://www.societyforscience.org/isef/
Regeneron International Science and Engineering Fair - Society for Science
science and engineering fairregeneroninternationalsociety
https://www.regeneron.com/
Regeneron | Pushing the Bounds of Science
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
regeneronpushingboundsscience
https://www.regeneron.ca/fr
Regeneron Canada
regeneroncanada
https://www.regeneron.fr/en
Regeneron France
regeneronfrance
https://www.regeneron.de/en
Regeneron Germany
regenerongermany
https://www.regeneron.it/
Regeneron Italy
regeneronitaly
https://www.regeneron.de/
Regeneron Germany
regenerongermany
https://www.regeneron.co.jp/
Regeneron Japan
regeneronjapan
https://www.regeneron.it/en
Regeneron Italy
regeneronitaly
https://www.regeneron.com/privacy-notice
Privacy Notice | Regeneron
We are committed to respecting your privacy. Learn more about Regeneron's privacy policies.
privacy noticeregeneron
https://www.crai.com/insights-events/events/aba-bundled-rebates-dissecting-the-regeneron-trial-webinar/
ABA Bundled Rebates: Dissecting the Regeneron Trial Webinar | Insights & Events | Charles River...
https://www.societyforscience.org/blog/regeneron-isef-finalists-are-making-mental-health-a-priority/
Regeneron ISEF finalists are making mental health a priority - Society for Science
Jul 15, 2022 - Regeneron ISEF finalists focused their research on improving mental health diagnosis and access to care. Their innovations include monitoring language use on...
regeneron isefmental health
https://bernardsudan.net/chloroquine-covid-19-sanofi-et-regeneron-pharmaceuticals-le-dessous-des-cartes/
Chloroquine, Covid-19, Sanofi et Regeneron Pharmaceuticals
Apr 4, 2023 - Le dessous des cartes sur la chloroquine, la Covid-19, Sanofi et Regeneron Pharmaceuticals avec des surprises
chloroquinecovidsanofietregeneron
https://www.clinicaltrialsarena.com/uncategorized/newssanofi-regeneron-phase-2-data-drug/
Sanofi and Regeneron report Phase 2 data of SAR236553/REGN727 drug - Clinical Trials Arena
May 27, 2012 - Sanofi and Regeneron Pharmaceuticals have announced additional positive results from the Phase 2 trial of SAR236553 / REGN727 in patients with heterozygous...
https://www.societyforscience.org/isef/science-to-medicine/
Science to Medicine: Perspectives from Regeneron Chief Scientific Officer George Yancopoulos -...
chief scientific officersciencemedicineperspectives
https://www.regeneron.com/terms
Terms of Use | Regeneron
View our terms and conditions govern your access to and use of Regeneron's websites.
terms of useregeneron
https://www.regeneron.com/responsibility/our-approach
Regeneron Corporate Responsibility Report & Goals Overview
Download the Regeneron corporate responsibility report and review our goals to see how we advance science, integrity, sustainable communities, and growth.
corporate responsibilityregeneronreportgoalsoverview
https://www.quiverquant.com/congresstrading/trade/House-8220660-62
REGENERON PHARMACEUTICAL INC CMN VERTEX PHARMACEUTICALS INCORPO FCMN EXELON CORPORATION CMN - Ro...
See details for Ro Khanna's trade of REGN - REGENERON PHARMACEUTICAL INC CMN VERTEX PHARMACEUTICALS INCORPO FCMN EXELON CORPORATION CMN on
vertex pharmaceuticalsexelon corporationregeneroninccmn
https://imprimeriedusquare.fr/vacancy/job/associate-scientist-immunology-at-regeneron-tarrytown-ny-b2xDTlczTitGVFhiWDBwaUZ6Qm00Qzg9
Associate Scientist, Immunology job at Regeneron Tarrytown, NY, US - imprimeriedusquare.fr
associate scientistimmunologyjob
https://healthwellnesstodaynewyork.com/article/836133116-regeneron-reports-second-quarter-2025-financial-and-operating-results
Regeneron Reports Second Quarter 2025 Financial and Operating Results | Health & Wellness Today New...
https://ipverse.greyb.com/ptab-web/cases/case-details/IPR2025-00456
Celltrion, Inc. v. Regeneron Pharmaceuticals, Inc. - IPR2025-00456 - IP Verse
Explore the PTAB proceeding IPR2025-00456 filed by Celltrion, Inc. against Regeneron Pharmaceuticals, Inc. on Jan 15, 2025. This includes filing dates,...
celltrionincvregeneronpharmaceuticals
https://ch.zonebourse.com/cours/action/REGENERON-PHARMACEUTICALS-10649/graphiques-comparatif/
Regeneron Pharmaceuticals, Inc.: Graphique de Cours Comparatif | REGN | US75886F1075 | Zonebourse...
Regeneron Pharmaceuticals, Inc.: Comparaison Graphique historique de cours Action Regeneron Pharmaceuticals, Inc. | REGN | US75886F1075 | Nasdaq
regeneron pharmaceuticals incgraphiquedecourscomparatif
https://www.ksby.com/teens-give-hope-for-future-with-regeneron-science-fair-projects
Teens give hope for future with Regeneron science fair projects
May 22, 2023 - Finalists competed for nearly $9 million in scholarships while sharing solutions to world problems like cancer, climate change and mass shootings.
give hopescience fairteensfutureregeneron
https://www.dcatvci.org/dcat-member-company-community/dcat-awards-scholarships-student-scientists-at-the-2024-regeneron-international-science-engineering-fair/
DCAT Awards Scholarships To Student Scientists at the 2024 Regeneron International Science &...
https://www.aiklaw.co.jp/en/whatsnewip/2023/05/15/4055/
Kluwer Patent Blog / Amgen v. Sanofi and Regeneron: Japan IP High Court overrules its own decision...
May 19, 2023 - Law,Patent,Syogo Abe,Yasuhiko Ikubo,Eiji Katayama
https://www.afslaw.com/perspectives/investigations-blog/regeneron-court-permits-government-pursue-false-certification
Regeneron Court Permits Government to Pursue False Certification Theory | ArentFox Schiff
Headlines that Matter for Companies and Executives in Regulated Industries
regeneroncourtpermitsgovernment
https://alachuachronicle.com/two-acps-students-earn-awards-in-regeneron-international-science-and-engineering-fair/
Two ACPS students earn awards in Regeneron International Science and Engineering Fair - Alachua...
May 20, 2024 - Two Alachua County Public Schools students earned awards in the Regeneron International Science and Engineering Fair in Los Angeles
science and engineering fair
https://landoncapital.net/shot-block-fda-rejects-regeneron-pharmaceuticals-nasdaq-regn-twice/
Shot Block: FDA Rejects Regeneron Pharmaceuticals (NASDAQ: REGN) Twice - Landon Capital
Aug 4, 2025 - Shot Block, FDA Rejects Regeneron Pharmaceuticals (NASDAQ: REGN) Twice Regeneron Pharmaceuticals faced a second rejection from the FDA for its lymphoma...
shotblockfdarejectsregeneron
https://garetina.com/clinical-trials/regeneron-r2176-3-amd-1417-capella/
Regeneron R2176-3-AMD-1417 CAPELLA | Georgia Retina Clinical Trials
Regeneron R2176-3-AMD-1417 CAPELLA | Learn about clinical trials offered by the Atlanta area's leading retina specialists at Georgia Retina.
regeneronamdcapellageorgiaretina
https://www.cafc.uscourts.gov/08-06-2024-2023-1334-novartis-pharma-ag-v-regeneron-pharmaceuticals-inc-audio-uploaded/
2023-1334: Novartis Pharma AG v. Regeneron Pharmaceuticals, Inc. - U.S. Court of Appeals for the...
Aug 6, 2024 - Oral argument audio posted: Novartis Pharma AG v. Regeneron Pharmaceuticals, Inc. (mp3) Appeal Number: 2023-1334 To listen to more oral argument recordings,...
https://azvma.org/be-a-judge-at-regeneron-international-science-engineering-fair-in-phoenix-may-2026/
Be a Judge at Regeneron International Science & Engineering Fair in Phoenix May 2026! - AzVMA
be a judge
https://druganalyst.com/Regeneron/Libtayo
Libtayo (cemiplimab) - Regeneron Sales History and Forecasts - DRUGANALYST
sales historycemiplimabregeneronforecasts
https://manufacturingchemist.com/regeneron-fujifilm-diosynth-biotechnologies-us-biomanufacturing-agreemement
Fujifilm Diosynth Biotechnologies signs $3bn biomanufacturing deal with Regeneron
The CDMO will produce drug products for Regeneron at its novel US biomanufacturing site in Holly Springs, North Carolina
deal withfujifilmdiosynthbiotechnologiessigns
https://www.floridafinancetoday.com/article/836133116-regeneron-reports-second-quarter-2025-financial-and-operating-results
Regeneron Reports Second Quarter 2025 Financial and Operating Results | Florida Finance Today
second quarter
https://www.limerickpost.ie/tag/regeneron/page/2/
Regeneron Archives - Page 2 of 3 - Limerick Post
archives pageregeneronlimerickpost
https://www.stemtimesconnecticut.com/article/836133116-regeneron-reports-second-quarter-2025-financial-and-operating-results
Regeneron Reports Second Quarter 2025 Financial and Operating Results | STEM Times of Connecticut
https://societyforscience.tfaforms.net/650
Regeneron ISEF 2023 General Volunteer Interest Form
general volunteer interestregeneron isefform
https://www.deepresearchglobal.com/t/Regeneron-Pharmaceuticals
Regeneron Pharmaceuticals | Deep Research Global
deep researchregeneronpharmaceuticalsglobal
https://rivka.me/regeneron-sts-finals-week-day-0/
Regeneron STS Finals Week: Day 0 - Rivka Lipkovitz
Mar 23, 2025 - I was honored to be selected as a finalist in the Regeneron Science Talent Search, which includes a weeklong trip in March where they do the final judging and...
finals weekregeneronstsdayrivka
https://www.oregontechnologytoday.com/article/836133116-regeneron-reports-second-quarter-2025-financial-and-operating-results
Regeneron Reports Second Quarter 2025 Financial and Operating Results | Oregon Technology Today
second quarter
https://headlineoftheday.com/2020/10/10/hhs-expects-over-1-mln-antibody-doses-from-regeneron-lilly-in-2020-trump-success-provides-impetus-for-the-rest-of-us/
HHS expects over 1 mln antibody doses from Regeneron, Lilly in 2020 [Trump success provides impetus...
https://www.areadevelopment.com/newsitems/4-4-2013/regeneron-pharmaceuticals-headquarters-expansion-hudson-valley-new-york683478.shtml
Regeneron Pharmaceuticals Plans Additional Expansion in Hudson Valley, New York - Area Development
Regeneron Pharmaceuticals, Inc., a biopharmaceutical research and development firm, will expand its corporate headquarters and laboratories in Westchester...
new york areaadditional expansion
https://www.roche.com/investors/updates/inv-update-2020-08-19b
Roche and Regeneron collaborate to significantly increase global supply of REGN-COV2...
Basel, 19 August 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) and Regeneron (NASDAQ: REGN) announced today that they are joining forces in the fight against...
https://www.societyforscience.org/regeneron-sts/
Regeneron Science Talent Search - Society for Science
science talent searchregeneronsociety
https://www.quantisnow.com/insight/regeneron-to-report-first-quarter-2026-financial-and-operating-results-6468784
Regeneron to Report First Quarter 2026 Financial and Operating Results and Host Conference Call and...
TARRYTOWN, N.Y., March 25, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its first quarter 2026...
https://moneyandmarkets.com/stocks-to-watch-today-walmart-regeneron-general-electric/
Stocks to Watch Today: Walmart, General Electric, Regeneron
May 29, 2020 - Volatility reigns as major indexes are set to open lower once again plus stocks to watch today in the Opening Bell.
stocks to watchgeneral electrictodaywalmartregeneron
https://www.regeneron.com/stories/rethinking-thrombosis-prevention
Rethinking Thrombosis Prevention | Regeneron
Learn how Regeneron is advancing investigational Factor XI antibodies to help prevent thrombosis while aiming to reduce bleeding risk.
rethinkingthrombosispreventionregeneron
https://www.regeneron.com/about/grants
Grants and Funding | Regeneron
Discover how Regeneron programs offer support and resources to researchers, healthcare providers, patients and their advocates, as well as our local...
grants and fundingregeneron
https://www.regeneron.com/science/technology
Regeneron Technologies
Explore Regeneron’s innovative technologies powering our antibody discovery and development and new therapeutic methods like gene editing and cell therapy.
regenerontechnologies
https://www.fiercebiotech.com/keyword/regeneron-pharmaceuticals
Regeneron Pharmaceuticals | Fierce Biotech
regeneronpharmaceuticalsfiercebiotech
https://fipa.bc.ca/biotechnology-company-regeneron-buying-23andme-for-256-million/
Biotechnology company Regeneron buying 23andMe for $256 million
biotechnology companyregeneronbuyingmillion
https://pharmaphorum.com/news/regeneron-gets-long-awaited-fda-okay-myeloma-drug
Regeneron gets long-awaited FDA okay for myeloma drug | pharmaphorum
Regeneron's bid to join the crowded US market for BCMA-targeted bispecific antibodies for multiple myeloma has finally been realised
regenerongetslongfdaokay
https://www.fiercebiotech.com/biotech/regenerons-gene-therapy-improves-hearing-11-children-rare-hearing-loss-disease?ref=theupwing.com
Regeneron gene therapy restores hearing in 10 of 11 children
Feb 24, 2025 - Among 11 participants with at least one post-treatment assessment, 10 demonstrated a notable hearing improvement at various decibel levels.
gene therapyregeneronrestoreshearingchildren
https://www.clinicaltrialsarena.com/news/ankyra-regeneron-combination-cscc/
Ankyra and Regeneron to trial ANK-101 and Libtayo combination
Nov 14, 2023 - Ankyra Therapeutics has partnered with Regeneron to assess ANK-101 in combination with Libtayo in cutaneous squamous cell carcinoma patients.
regenerontrialankcombination
https://www.appliedradiationoncology.com/articles/telix-and-regeneron-partner-to-advance-radiopharmaceutical-therapies
Telix and Regeneron Partner to Advance Radiopharmaceutical Therapies | Applied Radiation Oncology
regeneronpartner
https://salesandmarketingnetwork.com/news_release_bs.html?pipe=0000ac177000191&ID=2038005&key=VISTA+trial
News for Medical Sales Reps: Regeneron Announces FDA Acceptance of EYLEA(R) (aflibercept) Injection...
https://www.marketscreener.com/news/regeneron-s-eylea-dupixent-should-support-625-valuation-despite-competition-rbc-says-ce7e5bd8df8af021
Regeneron's Eylea, Dupixent Should Support $625 Valuation Despite Competition, RBC Says |...
Jan 27, 2026 - Regeneron Pharmaceuticals could see its core franchises, Eylea and Dupixent, impacted by new competitors this year, but the company's valuation remains...
https://www.bioworld.com/articles/691692-regeneron-taps-cytomx-tech-in-203b-bispecifics-deal
Regeneron taps Cytomx tech in $2.03B bispecifics deal | BioWorld
A preview of the next edition of BioWorld, Nov. 17, 2022
regenerontapstechbispecificsdeal
https://investimentoslucrativos.pt/tag/regeneron-pharmaceuticals/
Arquivo de regeneron pharmaceuticals - Investimentos Lucrativos
arquivoderegeneronpharmaceuticalsinvestimentos
https://healthpr.bg/2020/07/30/trump-big-pharma-trade-barbs-over-drug-pricing-eos-barda-gives-regeneron-350m-for-ebola-drugs/
Trump, Big Pharma trade barbs over drug pricing EOs; BARDA gives Regeneron $350M for Ebola drugs |...
https://www.lifesciencesipreview.com/big-pharma/ptab-grants-ipr-of-regeneron-eylea-patents-4629
PTAB grants IPR of Regeneron Eylea patents | Life Sciences Intellectual Property Review
PTAB grants IPR of Regeneron Eylea patents
https://www.southcarolinascitechwire.com/article/836133116-regeneron-reports-second-quarter-2025-financial-and-operating-results
Regeneron Reports Second Quarter 2025 Financial and Operating Results | South Carolina Sci-Tech Wire
https://thebcw.org/news/bcw-member-spotlight-regeneron-achieves-groundbreaking-fda-approval-in-gene-therapy/
BCW Member Spotlight: Regeneron Achieves Groundbreaking FDA Approval in Gene Therapy - Business...
The Business Council of Westchester is proud to spotlight one of our members, Regeneron Pharmaceuticals, on a truly historic milestone in medical innovation....
member spotlight
https://mammoth.bio/regeneron-and-mammoth-biosciences-collaborate-to-pursue-next-generation-crispr-based-gene-editing-for-multiple-diseases/
Regeneron and Mammoth Biosciences Collaborate to Pursue Next-Generation CRISPR-Based Gene Editing...
Apr 25, 2024 - Mammoth’s proprietary ultracompact CRISPR-based gene editing platform and Regeneron’s proprietary delivery technologies set to advance in vivo programs in...
https://www.hunterschools.org/news-detail?pk=1616370&fromId=239966
HCHS Science Research Students Attend the Regeneron STS Public Exhibition in Washington, DC
https://www.cmlviz.com/stocks/REGN/news/2015/07/07/REGN
Why Regeneron Stock Has Great Promise - CMLViz.com
regeneronstockgreatpromise
https://app.ortex.com/s/Nasdaq/REGN/holders
Regeneron Pharmaceuticals, Nasdaq:REGN | Holders - ORTEX
Institutional Holders in Regeneron Pharmaceuticals, Nasdaq:REGN
regeneronpharmaceuticalsnasdaqregnholders
https://www.dcatvci.org/top-industry-news/pharma-covid-roundup-news-from-moderna-pfizer-biontech-regeneron/
Pharma COVID Roundup: News from Moderna, Pfizer, BioNTech, Regeneron - DCAT Value Chain Insights
Sep 8, 2021 - The latest on COVID-19 vaccines/drugs, manufacturing, and testing from Moderna, Pfizer, BioNTech, Fosun Pharm, CSL, Regeneron, Roche, CureVac, Thermo Fisher,...
https://regeneron.de/nutzungsbedingungen
Regeneron Germany
regenerongermany
https://www.watervlietcityschools.org/regeneron-scientists-share-insights-into-biotech-careers-with-students/
Regeneron scientists share insights into biotech careers with students - Watervliet City School...
Feb 21, 2025 - Watervliet High School students recently had the chance to connect with local scientists and learn about the variety of careers in the world of STEM (science,...
share insights
https://www.societyforscience.org/blog/together-at-2023-regeneron-isef-pin-exchange/
Students from around the world come together at the 2023 Regeneron ISEF Pin Exchange - Society for...
May 16, 2023 - 2023 Regeneron ISEF finalists from 64 countries came together at the pin exchange to kick off competition week and trade pins representing their homes....
from around the world
https://www.techbulletinbarbados.com/article/836133116-regeneron-reports-second-quarter-2025-financial-and-operating-results
Regeneron Reports Second Quarter 2025 Financial and Operating Results | Tech Bulletin Barbados
second quarter
https://staging-jf.oechsli.dev/investigations/regeneron-pharmaceuticals/
Regeneron Pharmaceuticals, Inc. | Johnson Fistel
Shareholder rights law firm Johnson Fistel, LLP (www.JohnsonFistel.com) is investigating whether Regeneron Pharmaceuticals, Inc. ("Regeneron" or "the
regeneron pharmaceuticals incjohnson
https://www.quiverquant.com/congresstrading/trade/House-8221124-151
REGENERON PHARMACEUTICAL INC CMN - Ro Khanna Congressional Trade on May. 19, 2025
See details for Ro Khanna's trade of REGN - REGENERON PHARMACEUTICAL INC CMN on May. 19, 2025
ro khanna
https://uk.marketscreener.com/news/sanofi-and-regeneron-s-dupixent-approval-in-the-eu-as-the-first-targeted-medicine-to-treat-young-chi-ce7e50d3dd8dff21
Sanofi and Regeneron?s Dupixent approval in the EU as the first targeted medicine to treat young...
Apr 15, 2026 - Sanofi published the press releases attached hereto as Exhibits 99.1 and 99.2 which are incorporated herein by reference. Phase 2 studies of lunsekimig in two...
https://www.kztv10.com/teens-give-hope-for-future-with-regeneron-science-fair-projects
Teens give hope for future with Regeneron science fair projects
May 22, 2023 - Finalists competed for nearly $9 million in scholarships while sharing solutions to world problems like cancer, climate change and mass shootings.
give hopescience fairteensfutureregeneron
https://finviz.com/news/340052/regeneron-to-report-first-quarter-2026-financial-and-operating-results-and-host-conference-call-and-webcast-on-april-29-2026
Regeneron to Report First Quarter 2026 Financial and Operating Results and Host Conference Call and...
Stock screener for investors and traders, financial visualizations.
https://www.ophthalmologymanagement.com/news/2025/regeneron-provides-update-on-eylea-hd-injection-8-mg-supplemental-biologics-license-application/
Regeneron Provides Update on Eylea HD Injection 8 mg Supplemental Biologics License Application |...
Apr 21, 2025 - Conexiant Vision: Delivering trusted clinical content, deep audience engagement, and educational resources for eye care professionals. Discover more through...
https://www.fraudfighters.net/news/doj-files-second-qui-tam-lawsuit-against-regeneron-pharmaceuticals/
DOJ Files Second Qui Tam Lawsuit Against Regeneron Pharmaceuticals - TZ Legal - Fraud Fighters
Apr 17, 2024 - The United States announced that it has intervened in a False Claims Act case against New York-based Regeneron Pharmaceuticals Inc. (Regeneron).
qui tam lawsuit
https://societyforscience.tfaforms.net/659
Regeneron ISEF 2024 Grand Award Judging Interest Form
regeneron isefgrandawardjudginginterest
https://www.regeneron.com/stories/chrnb3-gene-reduced-cigarette-smoking
Can Genes Determine How Much You Smoke? | Regeneron
Mar 11, 2026 - Regeneron researchers found variants in the CHRNB3 gene linked to less cigarette consumption, offering new insights into the genetics of smoking behavior.
how muchgenesdeterminesmokeregeneron
https://hot-topics.multitox.pt/patrocinador/regeneron/
Regeneron - Hot Topics
regeneronhottopics
https://ipverse.greyb.com/unified-patent-court/cases/case-details/amgen-vs-regeneron-pharmaceuticals--apl-32765-2025
Amgen vs. Regeneron Pharmaceuticals - APL_32765/2025 - IP Verse
The case APL_32765/2025 was filed by the plaintiff Amgen against the defendant Regeneron Pharmaceuticals on 11 Jul, 2025.
amgenvsregeneronpharmaceuticalsapl
https://www.scifest.ie/News/Regeneron-ISEF-Regional-Awards/529711/Index.html
Regeneron ISEF Regional Awards | SciFest
SciFest is the largest second-level STEM fair programme in Ireland. Hosted locally in schools and regionally in third-level colleges, it is inclusive,...
regeneron isefregional awardsscifest
https://mozibox.com/jobs/294104
Medical Director, Clinical Development, Obesity (Cardiovascular/ Lipids) at Regeneron - Mozibox
Regeneron is hiring a Medical Director, Clinical Development, Obesity (Cardiovascular/ Lipids) in Tarrytown, NY +1. The Medical Director, Clinical Development,...
medical directorclinical developmentobesitycardiovascularlipids